Skip to Main Content
Don't have an account? Create Account

CDC Expands States’ Ability To Detect Zika

In August, the Centers for Disease Control and Prevention (CDC) sent about $2.5 million worth of laboratory supplies and equipment — including two diagnostic tests — to states to ensure they can meet the growing demand for testing and rapid identification of Zika infection.

CDC has invested in materials for two types of diagnostic tests:

  • MAC-ELISA, a CDC-developed test that detects antibodies that fight Zika infection, which can be found in the blood as early as four to five days after an infection occurs and can last for up to 12 weeks; and
  • Trioplex rRT-PCR, which can test for chikungunya, dengue, and Zika simultaneously.

The MAC-ELISA test has been deployed in 43 states, the District of Columbia, Puerto Rico, and nine Department of Defense (DOD) labs. The Trioplex rRT-PCR test has been sent to all states, the District, Puerto Rico, and 16 DOD labs.

America’s Essential Hospitals has established a resource page dedicated to this emerging public health threat. Visit this page regularly for new and updated information.

Share

About the Author

Michelle Rosenfeld is senior writer/editor at America's Essential Hospitals.